Increasing adoption of extracellular matrix in hernia and pelvic reconstruction surgeries promotes the growth of these products. For instance, abdominal wall hernia is amongst the commonest surgeries around the world.
Increasing incidence of congenital heart disease (CHD) and trauma injuries, several of which often result in repair and reconstruction procedures, is one of the key factors driving the market. According to the Centers for Disease Control and Prevention (CDC), about 40,000 neonates are born with CHD in U.S. each year.

This report provides a complete quantitative data and qualitative analysis on the global market for Extracellular Matrix (ECM) Patches. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Extracellular Matrix (ECM) Patches was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Extracellular Matrix (ECM) Patches is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Extracellular Matrix (ECM) Patches, including the following market information:
Global Extracellular Matrix (ECM) Patches Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Extracellular Matrix (ECM) Patches Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Extracellular Matrix (ECM) Patches Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Extracellular Matrix (ECM) Patches Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include Aziyo Biologics, Boston Scientific Corporation, Coloplast, DSM, Baxter, Medtronic, Admedus Ltd., MTF Biologics, Koninklijke DSM N.V., Smith and Nephew, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Bovine
Porcine
Others

Based on the Application:
Cardiac Repair
Vascular Repair and Reconstruction
Pericardial Repair
Dural Repair
Soft Tissue Repair
Wound Healing